COPD Exacerbation by SARS-CoV-2. A Cause of Future Poor Disease Control?
作者信息
Figueira-Gonçalves Juan Marco, Golpe Rafael
机构信息
Respiratory Department, Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Pneumology Department, Lucus Augusti University Hospital, Lugo, Spain.
出版信息
Open Respir Arch. 2024 Sep 24;6(4):100369. doi: 10.1016/j.opresp.2024.100369. eCollection 2024 Oct-Dec.
Abstract
摘要
相似文献
1
COPD Exacerbation by SARS-CoV-2. A Cause of Future Poor Disease Control?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引发的慢性阻塞性肺疾病（COPD）急性加重。会成为未来疾病控制不佳的一个原因吗？
Open Respir Arch. 2024 Sep 24;6(4):100369. doi: 10.1016/j.opresp.2024.100369. eCollection 2024 Oct-Dec.
2
[Exacerbation of obstructive pulmonary diseases by SARS-CoV-2 infection in patients treated in the Pulmonology Clinic of Târgu Mures].[在特尔古穆列什肺病诊所接受治疗的患者中，SARS-CoV-2感染导致阻塞性肺疾病加重]
Orv Hetil. 2023 Jan 15;164(2):43-50. doi: 10.1556/650.2023.32652.
3
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.一项前瞻性住院成人队列研究中，SARS-CoV-2 感染加重慢性阻塞性肺疾病对临床结局的影响。
J R Soc Med. 2023 Nov;116(11):371-385. doi: 10.1177/01410768231184162. Epub 2023 Jul 5.
4
Impact of COVID-19 Pandemic on the Exacerbation Rates in COPD Patients in Southern India - A Potential Role for Community Mitigations Measures.新冠疫情对印度南部 COPD 患者恶化率的影响-社区缓解措施的潜在作用。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 29;18:1909-1917. doi: 10.2147/COPD.S412268. eCollection 2023.
5
COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US.法国、德国、意大利、英国和美国在 COVID-19 之前和期间的 COPD 加重情况。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 25;19:1433-1445. doi: 10.2147/COPD.S451009. eCollection 2024.
6
Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.慢性阻塞性肺疾病患者因 SARS-CoV-2 住院与非 SARS-CoV-2 社区获得性肺炎住院的临床结局。
Respir Med. 2022 Jan;191:106714. doi: 10.1016/j.rmed.2021.106714. Epub 2021 Dec 9.
7
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease.杯状细胞增生增加慢性阻塞性肺疾病患者感染 SARS-CoV-2 的风险。
Microbiol Spectr. 2022 Aug 31;10(4):e0045922. doi: 10.1128/spectrum.00459-22. Epub 2022 Jul 13.
8
The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease.睡眠质量受损对慢性阻塞性肺疾病症状变化和未来恶化的影响。
Respir Res. 2023 Mar 30;24(1):98. doi: 10.1186/s12931-023-02405-6.
9
Outcomes among patients with chronic obstructive pulmonary disease after recovery from COVID-19 infection of different severity.不同严重程度 COVID-19 感染后康复的慢性阻塞性肺疾病患者的结局。
Sci Rep. 2024 Jun 16;14(1):13881. doi: 10.1038/s41598-024-64670-9.
本文引用的文献
1
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.英国已有气道疾病患者中新冠病毒住院治疗的长期影响：一项多中心纵向队列研究——PHOSP-COVID
ERJ Open Res. 2024 Jul 15;10(4). doi: 10.1183/23120541.00982-2023. eCollection 2024 Jul.
2
Outcomes among patients with chronic obstructive pulmonary disease after recovery from COVID-19 infection of different severity.不同严重程度 COVID-19 感染后康复的慢性阻塞性肺疾病患者的结局。
Sci Rep. 2024 Jun 16;14(1):13881. doi: 10.1038/s41598-024-64670-9.
3
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study.因 COVID-19 住院与季节性流感住院的长期结局比较：一项队列研究。
Lancet Infect Dis. 2024 Mar;24(3):239-255. doi: 10.1016/S1473-3099(23)00684-9. Epub 2023 Dec 14.
4
Long covid-mechanisms, risk factors, and management.长新冠的发病机制、危险因素和管理。
BMJ. 2021 Jul 26;374:n1648. doi: 10.1136/bmj.n1648.
5
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者病情加重的时间进程及恢复情况
Am J Respir Crit Care Med. 2000 May;161(5):1608-13. doi: 10.1164/ajrccm.161.5.9908022.
Zotero 插件